AI will inevitably bring revolutionary benefits to pharma, but the transformation will be more gradual and nuanced than in other industries, writes Bristol Myers Squibb’s chief digital and technology officer.
Saad Z. Usmani, MD, MBA, FACP, discusses how the MajesTEC-5 study, presented at ASH 2024, demonstrates the potential of teclistamab in combination with standard therapy…
Learn what to expect during dialysis, a lifesaving treatment for people with end-stage kidney disease….
We, for one, welcome our new cuttlefish overlords.
Check out who’s buying and selling in this week’s roundup of healthcare mergers, acquisitions and joint ventures.
Patrizia Cavazzoni, leader of the FDAs Center for Drug Evaluation and Research, is leaving the agency on Jan. 18
Smart ring maker Circular has announced its next gen Ring 2 with ECG functionality and AFib detection.
/PRNewswire/ — ScreenPoint Medical today announced the acquisition of Biomediq A/S, a research-based company focused on the research, development and…
A path forward for the US health insurance industry following the mixed public reaction to United Healthgroup CEO Brian Thompson’s tragic murder.
Unveiling extraordinary discoveries beneath the Earth’s surface: scientists challenge conventional theories with new findings in the mantle.
Combining two FDA-approved drugs, was found to extend lifespan, improving the effects of either drug alone
